View Published SNOMED CT Subset Metadata

Enhanced Services Diabetic drugs

Subset Name :   
Enhanced Services Diabetic drugs
Subset Original Id :   
Subset Type :   
Realm Concept

Refset FSN :   
Enhanced services general practice extraction - Diabetic drugs simple reference set (foundation metadata concept)
Refset Id :   
Refset Type :   

Subset Description :
This subset identifies the diabetic drugs as specified in the Pneumococcal vaccination and Immunisation business rules. These subsets are created using the XML format dm+d data and so within these subsets a small number of concepts are inactive (status 2 or 10) in the International Release. The concepts included are all valid VMPs and AMPs associated with the following VTMs: Glipizide Tolbutamide Glibenclamide Repaglinide Acarbose Glimepiride Metformin Insulin human Insulin glargine Nateglinide Gliclazide Rosiglitazone Pioglitazone Insulin aspart Insulin lispro Insulin aspart biphasic Rosiglitazone + Metformin Insulin glulisine Insulin detemir Insulin isophane human Insulin protamine zinc bovine Insulin isophane porcine Insulin lispro biphasic Insulin soluble bovine Insulin isophane biphasic porcine Insulin soluble human Insulin isophane biphasic human Insulin soluble porcine Exenatide Pioglitazone + Metformin Insulin zinc crystalline human Sitagliptin Sitagliptin + Metformin Vildagliptin Saxagliptin Liraglutide Saxagliptin + Metformin Dapagliflozin Canagliflozin Empagliflozin Dulaglutide Insulin mixed bovine Vildagliptin + Metformin Linagliptin Insulin zinc mixed human Linagliptin + Metformin Insulin degludec Lixisenatide Alogliptin Alogliptin + Metformin Dapagliflozin + Metformin Canagliflozin + Metformin Insulin degludec + Liraglutide Empagliflozin + Metformin Chlorpropamide Gliquidone Insulin glargine + Lixisenatide


Subset Status :   
Draft for Trial Use
Subset Status Date :   
Jun 12, 2019
Owner (Organisation name) :   
NHS Digital

Purpose and Scope

Usage 1 :

Usage Type :    
Usage Description :    
Intended for secondary uses purposes. Management information to support counts for establishing Enhanced Services activity used to determine Practice payments. Information on the specific business rules can be found here: These subsets are created using the XML format dm+d data and so within these subsets a small number of concepts are inactive (status 2 or 10) in the SNOMED CT International Release. The origin of these inactive concepts is the native XML dm+d and they are now inactive in the new International Release due to natural movement and updating of the International Release content. Work is underway to update the dm+d concepts to the new International release identifiers; at this point this mismatch will be resolved. If using the dm+d in SNOMED CT format the International Release relationships will enable migration to the replacement concept. The subsets as published in the current release data are applicable to the Enhanced Services year 2016-2017. This subset identifies the diabetic drug codes that to be used to identify patients are eligible under the Enhanced Services Pneumococcal vaccination and immunisation programme 2016-2017
Geographic Usage :    
Usage Categories:    
 Administrative; Data extraction

Scope :

Inclusion Criteria :   
Gender - not specified; Age group - any age; Sex - not specified
Subject Category :   
Prescribing; Health Care.Primary care; Chemicals and Drugs


Subset Release Category :   
UK Drug Extension
Language :   
Folder Name :   
File Name :   
Enhanced Services Diabetic drugs

Subset Licence Type :   
IHTSDO SNOMED CT® Licence; UKTC SNOMED CT® Licence; Open Government Licence

Metadata Version :   
Last Updated :   
Jun 11, 2019

Related Links

Subset download with descriptions :

UK Drug Extension releases